SAB Biotherapeutics is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. We show 10 historical shares outstanding datapoints in our SABS shares outstanding history coverage, used to compute SABS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SABS market cap history over the course of time is important for investors
interested in comparing SABS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SABS versus a peer is one thing; comparing
SABS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SABS can fluctuate over the course of history.
With this page we aim to empower investors researching SABS by allowing them to research the SABS market cap history. |
Free SABS Email Alerts:
Video: The Importance of Market Cap
